ACN Newswire Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
ACN Newswire Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million
ACN Newswire AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
ACN Newswire Focus Graphite Advances ESIA Reporting at Lac Knife and Accelerates Mineral Resource Expansion at Lac Tetepisca and Announces the Grant of Options and RSUs
ACN Newswire Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical’s Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
ACN Newswire Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
